Physician profile
Brian P Brett
NPI 1942386917
$9,348.94
in general payments reported to CMS, 2019-2025
43 companies · $1,613 in 2025
The $1,613 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,403 · 2020: $785 · 2021: $1,645 · 2022: $1,212 · 2023: $1,387 · 2024: $1,304 · 2025: $1,613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,304.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,795.01 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,392.28 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $885.65 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Pfizer INC. | $763.06 | 2019-2025 | |
| Glaxosmithkline, LLC. | $660.58 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $414.90 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $377.51 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $375.39 | 2019-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Amgen INC. | $302.59 | 2022-2025 | Repatha, Otezla, Otezla |
| Amarin Pharma, INC. | $297.96 | 2019-2023 | |
| Medtronic, INC. | $268.16 | 2022-2025 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Exact Sciences Corporation | $260.67 | 2023-2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $190.28 | 2019-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $186.84 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.07 | 2019-2025 | Jardiance |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Brett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.